More Starpharma Holdings Limited news
Starpharma Holdings LimitedASX: SPL

Starpharma signs DEP Research Agreement with US Biopharma Co

Dec 6, 2021 at 10:28 PM EST · Issued by Starpharma Holdings Limited

Filed with ASX · Dec 6, 2021 at 10:28 PM EST · 2 pages · English

On 6ix: 6ix.com/news/starpharma-signs-dep-research-agreement-with-us-biopharma-co

Starpharma Holdings Limited on 6ix

Earlier from Starpharma

  • VIRALEZE distribution agreement and launch in VietnamDec 2, 2021
  • VIRALEZE registered in Vietnam with launch this weekNov 30, 2021
  • AGM Chairman address and CEO presentationNov 29, 2021
  • Positive DEP phase 2 interim results in prostate cancerNov 25, 2021
  • VIRALEZE distribution and supply to VietnamOct 25, 2021

Later from Starpharma

  • VIRALEZE successfully launched in VietnamDec 13, 2021
  • Starpharma receives $7.7M R&D tax incentive refundJan 19, 2022
  • Starpharma - Quarterly Cashflow and Activities ReportJan 31, 2022
  • VIRALEZE sales and distribution in Saudi Arabia and GCCFeb 2, 2022
  • Interim Report and Half-Year Financial ResultsFeb 20, 2022
All Starpharma news releases↗

Follow Starpharma into a list and get an email when it puts out news.

Follow Starpharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer